作者
Arnaud Méjean,Alain Ravaud,Simon Thézenas,Sandra Colas,Jean‐Baptiste Beauval,Karim Bensalah,Lionnel Geoffrois,Antoine Thiery-Vuillemin,Laurent Cormier,Hervé Lang,Laurent Guy,Gwénaëlle Gravis,Frédéric Rolland,Claude Linassier,É. Lechevallier,Christian Beisland,Michael Aitchison,Stéphane Oudard,Jean‐Jacques Patard,C Théodore,Christine Chevreau,Brigitte Laguerre,Jacques Hubert,Marine Gross‐Goupil,Jean‐Christophe Bernhard,Laurence Albigès,Marc‐Olivier Timsit,Thierry Lebrét,Bernard Escudier
摘要
Cytoreductive nephrectomy has been the standard of care in metastatic renal-cell carcinoma for 20 years, supported by randomized trials and large, retrospective studies. However, the efficacy of targeted therapies has challenged this standard. We assessed the role of nephrectomy in patients with metastatic renal-cell carcinoma who were receiving targeted therapies.
PDF的下载单位、IP信息已删除
SYLH
热心市民小红花
LaTeXer
鸣笛
ED
昏睡的蟠桃
pluto
wu8577
LEMONS
yznfly
彭于彦祖
Rondab
iNk
卡卡西
核桃
yookia
挖掘机
shinysparrow
眯眯眼的衬衫
YH
皖公网安备34019202002308
